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Summary This study assessed the growth pattern, cellular organisation and chemosensitivity of established
human tumour cell lines growing as postconfluent cultures in 'V'-bottomed, 96-well microtiter plates. Cross-
sections of the colon (HT29, SW620, SWI 116), ovarian (A2780) and head and neck (UM-SCC-22B) car-
cinoma microcultures allowed in situ evaluation of the cellular organisation in the wells. After 5 days of
growth, every cell line had reached confluence, but each of them displayed a specific pattern of cell stacking
which ranged from two to ten layers. Postconfluent HT29 cells displayed morphologic features suggestive of
some degree of enterocytic differentiation. Growth and cytotoxicity could be studied reliably and reproducibly
in this system with the sulforhodamine B protein assay. Against HT29 postconfluent cultures, the EC50's (drug
concentrations producing absorbance readings 50% lower than those of non-treated wells) of 5-fluorouracil
and of the ether lipid, hexadecylphosphocholine, were 1 mm and 50 gM respectively. The possibility to perform
chemosensitivity tests using semiautomated microtiter plate technology supports further evaluation of this
system as an alternative antitumour drug testing model.
In the past four decades, worldwide efforts to discover and
develop new anticancer agents using murine leukaemias as
screening systems have produced drugs which are mainly
effective against rapidly proliferating tumours. In view of the
limited discovery of new anticancer agents for the treatment
of the most common human solid malignancies (e.g., lung,
colon, mammary carcinomas), current research is directed
towards the study of alternative laboratory models.
In a critical evaluation of the predictive value of in vitro
chemosensitivity assays, Phillips et al. (1990) pointed out
that: (a) besides the inherent chemosensitivity of tumour
cells, other factors such as drug pharmaco-kinetics/-dynamics
and the biology of solid tumours significantly influence the
success rate of chemotherapy in vivo; and, (b) the lack of
simulation of those conditions in vitro is a major limitation
to the improvement of the predictability of this type of tests.
Therefore, an ideal in vitro tumour model should mimic the
organisational structure and the heterogeneity in biologic
characteristics found in human tumours. Several investigators
have shown that multicellular spheroids display a degree in
complexity which is intermediate between the in vivo neoplas-
tic cell deposits and monolayered tumour cell cultures
(reviewed by Mueller-Klieser, 1987 and Sutherland, 1988).
However, the use of spheroids specifically for new
antitumour drug screening and chemosensitivity testing has
been carried out only on a limited scale because of technical
limiting-factors.
Other investigators have used either postconfluent (Kruse
& Miedema, 1965; Skehan et al., 1986; Pelletier et al., 1990)
or plateau-phase (Twentyman, 1976; Drewinko et al., 1981)
tumour cell cultures in order to increase the degree with
which in vivo cell-cell interactions, growth physiology and
microenvironment conditions are simulated in vitro. It has
been suggested that results generated with these systems more
closely resemble those obtained with spheroids and with in
vivo models than those obtained with monolayer cell cul-
tures.
The objective of this study was to evaluate the growth
pattern and cellular organisation of human tumour cell lines
growing as postconfluent cultures (two or more layers of
cells) in 'V'-bottomed, 96-well microtiter plates. We also
assessed the feasibility of using the sulforhodamine B (SRB)
assay to study cytotoxicity in this system.
Materials and methods
Chemicals and drugs
Dulbecco's Modified Eagle's Medium (DMEM) was pur-
chased from Flow Laboratories (Irvine, Scotland); foetal calf
serum (FCS) was from Gibco (New York, USA); 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MIT),
5-fluorouracil (5FU) and sulforhodamine B were from Sigma
Chemical Co. (St Louis, USA); spectrophotometric graded
dimethyl sulfoxide (DMSO) was from Baker Chemicals B.V.
(Deventer, Holland). HistoresinR was from Reichert/Jung
(Salzburg, Austria). Hexadecylphosphocholine (HPC), also
known as miltefosine, was a kind gift of Dr P. Hilgard (Asta
Pharma, Bielefeld, Germany). All other chemicals were of
standard analytical quality commercially available.
Cell culture andplating
HT29, SW620 and SWl 116 human colon adenocarcinoma
cell lines were obtained from the American Type Culture
Collection (Rockville, USA). UM-SCC-22B (22B) human
head and neck squamous cell carcinoma line was a gift of Dr
T. Carey (University of Michigan, USA). The A2780 human
ovarian carcinoma cell line was obtained from Dr R.F. Ozols
(NCI, Bethesda, USA) and MCF-7 mammary carcinoma
cells from Dr K. Cowan (NCI, Bethesda, USA).
Detailed description of routine cell culture and plating
procedures used during these experiments were reported
elsewhere (Keepers et al., 1991). Briefly, mycoplasma-
negative cells were maintained without antibiotics in DMEM
supplemented with 5% FCS and 1 mM L-glutamine in a
37'C, 5% C02, 95% humidified air incubator. Exponentially
growing cells were trypsinised and resuspended in antibiotic-
containing medium (50 ,lg gentamicin ml-'); single cell
suspensions displaying > 90% viability by trypan blue dye
exclusion were subsequently counted and seeded (15,000
cells/50 il/well) in 96-well plates with 'V'-shaped bottoms
(Greiner Labortechnik, Solingen, Germany).
Twenty-four h after seeding, 100 ,l4 of medium were added
to each well. From the second day after plating until the end
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of the experiments, culture medium was gently aspirated and
replaced by fresh medium (150 lI/well) once daily.
Histologicalprocedures
On days 5 and 10 after plating, culture medium from plates
assigned for cross-sections was aspirated, wells were rinsed
once with PBS and cultures were fixed in situ with 1%
phosphate-buffered gluteraldehyde (pH=7.3) for at least 2 h.
Fixed cultures were washed twice with the same buffer,
dehydrated in ascending ethanol series and embedded in
150,sl glycol-methacrylate-containing plastic resin (His-
toresinR), using the protocol supplied by the manufacturer.
After polymerisation, individual wells (n = 6) were sawed
apart from the microtiter plate and re-embedded en bloc in a
larger mould with the same resin. Each block was then
sagitally cross-sectioned (Jung-K Microtome; Reichter-Jung)
in two regions: in the centre of the 'V'-shaped bottom and in
a region corresponding approximately to one third of the
distance between the centre and the edge of the well bottom.
At least twenty-four, 5fm thick, serial cross-sections from
each of these regions were collected on microscope glass
slides and stained with dilute toluidine blue or with PAS
(periodic acid-Schiff)/hematoxylin. A PAS-positive staining
(red colour) indicates the presence of cellular carbohydrates
(e.g., mucins) (Cook, 1990). Cross-sectioning experiments
were repeated at least three times.
Chemosensitivity assessment
Chemosensitivity tests were carried out using HT29 cells and
two drugs: 5FU and the ether lipid, HPC (Hilgard et al.,
1988). These two drugs were specifically selected because they
produced dose-response curves with markedly different
profiles in a previous series of experiments using
monolayered cultures. Stock solutions and test concentra-
tions were prepared and used essentially as described in that
manuscript (Keepers et al., 1991). Plates received drug
(150 .LI/well) on day 5 following cell seeding. After 24 h of
drug exposure, wells were rinsed once with fresh medium and
then incubated for another 4 days in the absence of drugs
and with daily medium renewal until cytotoxicity was
assessed. The drug-response patterns of 5FU and HPC were
obtained with the MTT and SRB assays and compared with
cell numbers from a third set of microplates where medium
was aspirated, cells from replicate wells (n = 6/drug concent-
ration) were trypsinised (15 min/37°C), carefully resuspended
and immediately counted with an automatic cell counter
(Sysmex, CC-i 10, Tokyo, Japan).
SRB assay
The SRB assay was performed essentially as described before
(Skehan et al., 1990), however, some variations in the basic
protocol were also tested in order to optimise the assay for
postconfluent cultures. Briefly, cells were fixed by adding
50 Ill/well of 50% trichloroacetic acid and incubating for 1 or
2 h at 4°C. Plates were then rinsed five times with tap water
and air dried. Microcultures were stained for either 0.5, 1, 1.5
or 2 h after the addition of 50 j.l of 0.4% SRB. In order to
remove unbound dye, a different number of washing steps
with 1% acetic acid was tested. To solubilise bound dye,
wells received 150 lAl of 10 mM Tris base and were exposed to
15 min of ultrasonic vibration while floating in an ultrasonic
cleaner (Branson 5200). Absorbance of each well was read at
450 nm (a suboptimal wavelength required to produce absor-
bance readings within the linearity range of the assay) using
a microtiter plate reader (Titertek Multiskan MCC/340; Flow
Laboratories) interfaced with an Olivetti PC M19 microcom-
puter.
In order to evaluate the range of linearity between cell
numbers and absorbance readings, exponentially growing
HT29 cells were trypsinised from culture flasks, counted and
plated at the highest cell density in 200 fl medium/well.
Serial dilutions were prepared by transporting 100 tlI cell
suspension into immediately neighbouring wells containing
100 1l medium. Cells were allowed to attach for 4h before
the SRB assay was performed.
MTTassay
The MTT assay was performed using a modification of the
protocol reported by Alley et al. (1988). After 4 h incubation
with MTT solution, the large numbers of formazan crystals
in postconfluent cultures were solubilised with 150 lI of
DMSO/0.5% FCS plus 15 min of ultrasound vibration ap-
plied to water floating plates in an ultrasonic cleaner (Bran-
son 5200). The absorbance of each well was measured at
540 nm using a microtiter plate reader.
Data management andanalysis
Data from the microplate reader were transferred to floppy
disks using Titersoft E.I.A. software (Flow Laboratories).
Subsequent data analysis was performed within Symphony
software (Lotus, Cambridge, USA). A P value (Student's




Plates observed under the light microscope 4 h after seeding
revealed that cell sedimentation had taken place preferen-
tially in the centre of the 'V'-shaped bottom, independently
of the specific tumour cell type. When cells were seeded in
larger volumes, e.g., 100 LIl medium, they sedimented in the
centre and in the periphery of the well to the same extent
(data not shown). A confluent cell monolayer was seen on
the third day after plating, except in the case of 22B and
SWI 116 which needed another 24-48 h to become globally
confluent. In all cell types tested, culture confluence and
multilayering followed a centrifugal pattern, always starting
initially in the centre of the wells.
On the 4th day after plating, MCF-7 cells became very
weakly attached to the plastic substratum and were stripped
off the well whenever medium substitution was performed.
This could not be avoided by plate centrifugation prior to
medium manipulation. Therefore, MCF-7 was excluded from
further studies.
The postconfluent status of the microcultures and
variability in spatial organisation at the time of sectioning
was confirmed by the presence of a continuous basal cell
layer superposed by another two to four cell layers, in the
case of HT29 (Figure la), and up to 10 layers of SW620 cells
(Figure 1). By the evaluation of serial cross-sections, it was
noted that groups of HT29 cells formed dome-like structures
with a hemicystic shape. These structures were composed of
large cells, displaying some vacuolisation, focally bulging
from the plastic substratum and thus delimiting a lumen.
Small amounts of darkly-staining inclusions were sometimes
seen in the lumen of the domes, but we could not identify the
origin of this material. In cross-sections performed 10 days
after plating, the domes had increased in number and height,
being formed by a larger number of cells than that observed
in the 5-day cultures (Figure lb-Id). The cytoplasm of
HT29 cells cross-sectioned 5 or 10 days after plating was
PAS-positive. In contrast, less than 30% of HT29 cells main-
tained under standard conditions (subconfluent cultures)
showed a PAS-positive reaction (not shown).
In the cross-sections of SW620 (Figure le), the process of
cell stacking was correlated to the well geometry: it was
maximal at the very centre ofthe 'V'-shaped bottom, while at
the periphery of the well bottom, close to the walls of the
well, cells actually formed a confluent monolayer or were
organised into two to three layers at most. In the centre of
the well, there were subregions where groups of 5-8 cells
were very closely attached to each other, and other regions662 P.E. PIZAO et al.
where the inter-cellular spaces were relatively large. SW620
cells grown as sub- or postconfluent cultures were PAS-
negative and did not display any morphological features of a
differentiated phenotype. A2780 cells displayed a globally
confluent monolayer superimposed by compact cell clusters
of different sizes, containing up to 15 cells without any signs
of differentiation (Figure If). These cell clusters were also
more frequent in the centre of the wells, while a single layer
of cells was observed at the periphery of the plastic subs-
tratum. SWI116 and 22B displayed similar microculture or-
ganisation 5 days after plating: a confluent monolayer ofcells
was the consistent feature; a second layer of cells was seen in
less than 50% of the cross-sections and occupied small areas
restricted to the centre of the wells (not shown).
The cross-sections obtained after 10 days ofculture did not
show any significant increase in the maximum number ofcell
layers of any of the tumour lines studied. Nonetheless, on
day 10, the process of multiple cell layering was prevalent in
larger areas of the plastic substratum.
Growth and chemosensitivity
According to the protocol described by Skehan et al. (1990),
cells were optimally stained if exposed to the SRB solution
for 30min after 1 h of TCA fixation. In our experiments,
there was no need for a longer incubation with TCA. Never-
theless, absorbance readings from 10-day old HT29 post-




Figures la-lf Photomicrographs of in situ cross-sections of postconfluent microcultures prepared from individual 'V'-bottomed
wells as described in 'Materials and methods'. a, shows PAS-positive HT29 cells after 5 days in culture. The cells are tightly packed
into a maximum of 3-5 layers. At this time point, dome-like structures of hemicysts could be observed, focally bulging from the
plastic substratum and delimiting a lumen sometimes containing darkly-staining inclusions of indeterminate origin. After 10 days in
culture, the number and size of these domes increased: b-d, depict serial cross-section taken from a single HT29 dome,
demonstrating the 3-dimensional architecture of this structure. b, shows the cross-section at the edge of the dome which appears as
a cluster of cells without a lumen; further inwards, c, shows the beginning of the formation of a lumen containing some
darkly-staining inclusions; d, reveals the structure of the same dome at the region where it reaches its maximum height. e, Plates
containing SW620 cells and cross-sectioned at 5 days after seeding showed a maximum of ten layers of cells at the centre of the
'V'-shaped wells. Five days after plating, A2780 cells formed confluent monolayers superimposed by clusters containing up to 15
cells showing no signs of morphological differentiation f. a-d, PAS/hematoxylin-stained; e and f, toluidine blue-stained
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lower than those obtained after 1 h of SRB staining,
independently of the number of washing steps under acidic
conditions (data not shown). No improvement in the assay
results was gained with staining periods longer than 1 h and
more than five washing steps to remove unbound dye (not
shown). Therefore, the optimised SRB test used in the addi-
tional experiments reported here included 1 h of TCA
fixation followed by 1 h of SRB staining and five washing
steps with 1% acetic acid.
The necessity for daily medium substitutions to support
the cell growth during 10 days of incubation was initially
considered as a probable source of artifacts (cell loss). How-
ever, an absolute need for plate centrifugation immediately
before medium aspiration was only seen with A2780 cells.
Another problem was the occasional aspiration of large cell
clumps that took place whenever the Pasteur pipet would
accidentally touch the bottom of the well. Such involuntary
cell aspiration could be easily detected by macroscopic
examination of air-dried, SRB-stained wells and marked to
be excluded of the results later.
Linearity between increasing HT29 cell numbers and SRB
absorbance readings was observed until cell counts reached
approximately 106 cells/well (Figure 2). Since hemacytometer
countings of 10-day old microcultures of the tumour lines
tested never exceeded 0.9 x 106 cells/well, this protocol for
the SRB assay was ultimately adopted for use with post-
confluent microcultures.
Figure 3 illustrates the growth curves of five cell lines as
measured with the SRB assay. All cell lines displayed a
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Figure 2 Relationship between cell numbers and absorbance
readings in the SRB assay (r = 1.0). HT29 cells were seeded at the
indicated cell densities and allowed to attach for 4 h. Each point
represents the mean and standard deviation (s.d.) of four rep-
licates. If not indicated, s.d. bars are within the size of the
symbols. O.D. = optical density.
initial period of fast growth followed by a plateau-like phase.
Using HT29 cells, a comparison was made between SRB and
MTT readings. Both assays predicted a deceleratory profile
in the rate of absorbance increments with time, however, the
ratio between absorbance readings on day 5 and day 1 was
4.2 and 2.6 for measurements with the SRB and MTT,
respectively.
Figure 4 displays a comparison among cell countings,
MTT- and SRB-determined drug-response profiles of HT29
cells after exposure for 24 h to 5FU or HPC. Overall, the
three assays documented very similar drug-response curves
and no significant difference among their respective EC50's
(drug concentration producing absorbance readings 50%
lower than those of non-treated wells) was observed. Using
postconfluent cultures, 5FU and HPC prompted dose-
response curves with very different profiles. With a mean
EC50 = 50 ± 8gM, HPC was significantly more cytotoxic than
5FU (EC50 = 1 ± 0.1 mM). In addition, the ether lipid pro-
duced a steeper dose-response curve than 5FU.
Discussion
We have shown that tumour cells from various origins can be
cultured in 96-well 'V'-bottomed microtiter plates until the
point they reach postconfluence. The pattern of proliferation
and cell-cell interactions observed with each cell line was very
reproducible; however, they varied considerably among the
cell lines tested and, like in the multicellular spheroid model,
were probably correlated to culture conditions as well as to
certain phenotypic characteristics such as differentiation, his-
tology and type of tumour lesion where the cell line was
originated.
MCF-7, a mammary carcinoma cell line derived from a
malignant pleural effusion, could not withstand medium
substituting procedure and, therefore, could not be used in
this system. It has been reported that MCF-7 and other cells
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Figure 3 Growth curves of HT29 (0), SW620 (0), SWI116
(0), 22B (O) and A2780 (+) tumour cell lines as determined by
the SRB assay. HT29 formazan production was also measured
with the MTT assay (A). Absorbance measurements for the
MTT and SRB assays were performed at 540 and 450 nm, respec-
tively. A plating density of 15,000 cells/well was used for all cell
types. Points represent the means of at least three separate
experiments. s.d. were <20%.
[5FU] FM
Figure 4 Dose-response curves of HT29 cells exposed to HPC a,
or 5FU b, during 24 h on day 5 after plating. On day 10,
cytotoxic effects measured with the MTT (0), SRB (A) and
automatic cell counting (+) were compared, normalised and
expressed as a percentage of non-treated cells. In the curves
corresponding to the semi-automated assays, points and s.d. are
means of triplicate wells from a representative experiment. The
points concerning the automatic cell counting procedures repre-
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spheroids (Yuhas et al., 1978). Interestingly, MCF-7 cells
selected with increasing concentrations of doxorubicin and
displaying the multidrug-resistance phenotype could be
grown as postconfluent cultures and did not present any
problems of detachment from the 'V'-bottomed wells (not
shown). As observed with other models of cell aggregates, it
is unlikely that postconfluent culture systems can be emp-
loyed with an infinite number of tumour cell lines, despite of
the technical simplicity of the described system.
The choice of 'V'-bottomed microtiter plates allowed us to
develop culture conditions favouring confluence and multiple
cell-layering in the centre of the well bottom at an earlier
time point than it would take place on a flat-bottomed well.
Ultimately, the conic geometry of the wells (instead of a flat
bottom) also became a technical advantage for it allowed
faster solubilisation of MTT formazan crystals and SRB
stain, possibly because 'V'-shaped bottoms submerged in the
water were more efficiently exposed to ultra-sound vibra-
tion.
The HT29 cell line displays anaplastic features under stan-
dard culture conditions, however, it can differentiate into
enterocyte-like cells when grown as xenografted tumours in
nude mice (Osieka et al., 1977) and if cultured in glutamine-
(Viallard et al., 1986) or glucose-deprived medium in vitro
(Chantret et al., 1988; Pinto et al., 1982). The appearance of
domes has been considered as a functional differentiation
process in HT29 cell cultures because these structures are a
consequence of transepithelial fluid transport with subsequent
entrapment of fluids between the cells and the substratum
(Fantini et al., 1986; Lever, 1982). More recently, it has been
demonstrated that postconfluent cultures of HT29 are in fact
heterogeneous and formed by a majority of undifferentiated
cells and a small proportion of columnar absorptive and
mucus cells (Lesuffleur et al., 1990). Using monoclonal
antibodies to human colorectal epithelium, Richman &
Bodmer (1987) have demonstrated that HT29 cells, but not
SW620 (cell line derived from a metastatic lymphnode
lesion), show reactivity with mucus-related and columnar
cell-specific antibodies. Our results showed that HT29 cells
also formed dome-like structures in 'V'-bottomed wells after
5 days in culture. In addition, cross-sections of postconfluent
HT29, but not of SW620, stained positively with PAS, a
histological staining procedure used to demonstrate the
presence of cellular carbohydrates, including mucins. Only a
minority of HT29 cells (<30%) kept as subconfluent cultures
yielded a positive PAS reaction, while SW620 cells remained
PAS-negative if cultured under such conditions. These data
indicated that, under our experimental conditions, post-
confluent cultures of HT29 cells displayed some features of a
differentiated phenotype. The growth curves of postconfluent
microcultures obtained with the SRB assay showed that
HT29 cells were entering a plateau by the time cross-sections
were made. From day 1 to day 5 after plating, the numbers
of HT29 and SW620 cells in 'S -phase, studied by 3H-
thymidine incorporation and autoradiography techniques,
were reduced by 40%-50% (manuscript submitted for pub-
lication). Cells grow exponentially or semi-exponentially
when medium conditions are ideal. As cell density increases,
medium exhaustion (including glucose) is one of the condi-
tions prompting growth deceleration and was possibly cor-
related to HT29 differentiation in our system. In addition,
complex autocrine and/or paracrine growth factor loops
(Garrouste et al., 1991; Hafez et al., 1990), cell/extracellular-
matrix interactions (Daneker et al., 1989) and the presence of
specific intercellular junctional structures (Dertinger et al.,
1984) are processes intrinsically correlated to cellular spatial
organisation and can modulate differentiation and other
characteristics (e.g., growth and chemosensitivity) of post-
confluent cultures. Taking into account that subpopulations
of HT29 which are committed to differentiation also show
greater growth adaptability to methotrexate and 5FU
(Lesuffleur et al., 1991), our culture system may pose as an
alternative to study particular biochemical conditions which
might be involved in the process of anticancer drug
metabolism and resistance.
Several investigators have reported that results obtained
with the MTT assay are directly proportional to a limited
range of cell numbers (Twentyman & Luscombe, 1987;
Arnould et al., 1990; Heo et al., 1990; Ruben & Neubauer,
1987; Keepers et al., 1991). Under the conditions we emp-
loyed, the linearity between MTT readings and HT29 cell
counts was lost by the time microcultures reached post-
confluence (data not shown). Our results demonstrated that
the SRB assay can be successfully employed as a simple, fast
and reproducible test to assess the chemosensitivity of heavily
dense postconfluent microcultures. Dose-response curves
obtained with the SRB assay were almost identical to those
obtained with cell counts and the MTT assay. If in one hand
the SRB values may be directly correlated with microculture
protein content and number of cells, the same interpretation
may not be attributed here to MTT results. However, it has
been documented that the MTT assay allows the assessment
of cell activation even in the absence of cell proliferation
(Kondo et al., 1966; Mitsudomi et al., 1990; Maehara et al.,
1987a, 1987b; Anai et al., 1987; Kupichik et al., 1990). The
fact that we found no statistically significant difference
among EC50's determined simultaneously by automatic cell
counting, MTT and SRB tests may be considered as an
indication that, under certain circumstances, the tetrazolium-
based assay can be used to estimate cytotoxicty measuring
cell activation indices instead of cell numbers. It has to be
established if this will remain true when other drugs, other
treatment protocols and other cell lines are tested.
The study of anticancer drug absorption, distribution,
metabolism, excretion and toxicity ultimately requires the use
of preclinical in vivo models. Nevertheless, primary screening
of dozens of thousands of candidate compounds using
animal tumour models is technically and ethically
inconceivable. Thus the need for adequate in vitro screening
systems. The advantages and problems of the most com-
monly used in vitro chemosensitivity assays have been
recently reviewed by Hoffman (1991). His study pointed out
that common denominators among the methods which
attempt to simulate or preserve the complex biology and
architecture of solid tumours (e.g., spheroids and 3-
dimensional histocultures) are labour intensiveness and tech-
nical difficulties. The two-tumour assay developed by Corbett
et al. (1992) has the advantage of allowing the simultaneous
testing of leukaemia- and carcinoma-derived cells in order to
identify potential solid-tumour-specific drugs. However, this
method is likely to present the same technical limitations of
other types of clonogenic assays. In addition, it has only been
used with a limited number of solid tumour types, namely:
colon, pancreatic, and, more recently, mammary carcinoma
cells (Biernat et al., 1992). Ongoing experiments in our
laboratories have shown that it is possible to obtain mul-
tilayered postconfluent cultures using a large number of other
human and murine cell lines of different origins: gliomas,
squamous cell carcinoma and prostate, lung, and colon
tumours, in addition to cells selected for the multidrug resis-
tance phenotype. The opportunity to use such a diversity of
established cell lines is an advantage in the context of in vitro
chemosensitivity testing. The inconvenience of daily medium
substitutions required by postconfluent cultures can be tack-
led by automation of this procedure. In that case, the system
described in this paper would represent a simpler and faster
method to obtain cell cultures displaying some degree of
3-dimensional cell-cell interactions. It must be established if
the use of this system will also result in any improvement in
the reliability and predictability of in vitro chemosensitivity
tests. The possibility of combining postconfluent cell cultures
with semiautomated microtiter plate technology to assess
chemosensitivity supports further evaluation of this system.
In an initial study including three cell lines, we have now
compared the cytotoxic effects of three conventional and four
investigational chemotherapeutic agents on sub- and post-
confluent cultures (manuscript in preparation). These tests
have corroborated the good reproducibility of experiments
using postconfluent cultures. In addition, marked differences
in chemosensitivity have been noted between the two types ofPOSTCONFLUENT CELL CULTURES 665
culture system and they varied significantly depending on the
cell line and the drug tested.
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